3 of Wall Street’s Favorite Stocks We Keep Off Our Radar

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

At StockStory, we look beyond the headlines with our independent analysis to determine whether these bullish calls are justified. That said, here are three stocks where Wall Street may be overlooking some important risks and some alternatives with better fundamentals.

FormFactor (FORM)

Consensus Price Target: $138.63 (7.3% implied return)

With customers across the foundry and fabless markets, FormFactor (NASDAQ:FORM) is a US-based provider of test and measurement technologies for semiconductors.

Why Is FORM Not Exciting?

1. Muted 3.8% annual revenue growth over the last five years shows its demand lagged behind its semiconductor peers
2. Competitive supply chain dynamics and steep production costs are reflected in its low gross margin of 42.8%
3. Ability to fund investments or reward shareholders with increased buybacks or dividends is restricted by its weak free cash flow margin of 8.4% for the last two years

At $129.22 per share, FormFactor trades at 35.1x forward P/E. Dive into our free research report to see why there are better opportunities than FORM.

Kulicke and Soffa (KLIC)

Consensus Price Target: $106.67 (14.2% implied return)

Headquartered in Singapore, Kulicke & Soffa (NASDAQ: KLIC) is a provider of production equipment and tools used to assemble semiconductor devices

Why Are We Cautious About KLIC?

1. Customers postponed purchases of its products and services this cycle as its revenue declined by 4.7% annually over the last five years
2. Operating profits fell over the last five years as its sales dropped and it struggled to adjust its fixed costs
3. Free cash flow margin dropped by 18.1 percentage points over the last five years, implying the company became more capital intensive as competition picked up

Kulicke and Soffa’s stock price of $93.38 implies a valuation ratio of 15.6x forward P/E. Read our free research report to see why you should think twice about including KLIC in your portfolio.

Verisk (VRSK)

Consensus Price Target: $237.71 (31.8% implied return)

Processing over 2.8 billion insurance transaction records annually through one of the world's largest private databases, Verisk Analytics (NASDAQ:VRSK) provides data, analytics, and technology solutions that help insurance companies assess risk, detect fraud, and make better business decisions.

Why Are We Hesitant About VRSK?

1. 1.7% annual revenue growth over the last five years was slower than its business services peers
2. Earnings growth over the last two years fell short of the peer group average as its EPS only increased by 8% annually

Verisk is trading at $180.32 per share, or 22.1x forward P/E. If you’re considering VRSK for your portfolio, see our FREE research report to learn more.

Stocks We Like More

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.